X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. BIOCON LTD FDC LTD./
BIOCON LTD
 
P/E (TTM) x 29.1 82.9 35.1% View Chart
P/BV x 6.1 7.8 77.7% View Chart
Dividend Yield % 0.8 0.2 491.5%  

Financials

 FDC LTD.   BIOCON LTD
EQUITY SHARE DATA
    FDC LTD.
Mar-14
BIOCON LTD
Mar-17
FDC LTD./
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1441,162 12.4%   
Low Rs79483 16.4%   
Sales per share (Unadj.) Rs47.6194.6 24.4%  
Earnings per share (Unadj.) Rs7.634.4 22.1%  
Cash flow per share (Unadj.) Rs9.048.3 18.7%  
Dividends per share (Unadj.) Rs2.251.00 225.0%  
Dividend yield (eoy) %2.00.1 1,662.9%  
Book value per share (Unadj.) Rs47.5241.9 19.7%  
Shares outstanding (eoy) m177.83200.00 88.9%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.34.2 55.3%   
Avg P/E ratio x14.623.9 61.2%  
P/CF ratio (eoy) x12.317.0 72.5%  
Price / Book Value ratio x2.33.4 68.9%  
Dividend payout %29.62.9 1,017.3%   
Avg Mkt Cap Rs m19,784164,440 12.0%   
No. of employees `000NA9.2 0.0%   
Total wages/salary Rs m1,2217,470 16.3%   
Avg. sales/employee Rs ThNM4,213.9-  
Avg. wages/employee Rs ThNM809.0-  
Avg. net profit/employee Rs ThNM745.2-  
INCOME DATA
Net Sales Rs m8,45938,911 21.7%  
Other income Rs m3941,571 25.1%   
Total revenues Rs m8,85240,482 21.9%   
Gross profit Rs m2,0709,795 21.1%  
Depreciation Rs m2492,772 9.0%   
Interest Rs m31260 11.9%   
Profit before tax Rs m2,1848,334 26.2%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6061,616 37.5%   
Profit after tax Rs m1,3536,881 19.7%  
Gross profit margin %24.525.2 97.2%  
Effective tax rate %27.719.4 143.0%   
Net profit margin %16.017.7 90.5%  
BALANCE SHEET DATA
Current assets Rs m4,35540,477 10.8%   
Current liabilities Rs m1,79216,783 10.7%   
Net working cap to sales %30.360.9 49.8%  
Current ratio x2.42.4 100.8%  
Inventory Days Days4460 74.6%  
Debtors Days Days2583 29.8%  
Net fixed assets Rs m3,02545,073 6.7%   
Share capital Rs m1791,000 17.9%   
"Free" reserves Rs m8,24347,377 17.4%   
Net worth Rs m8,45348,377 17.5%   
Long term debt Rs m1121,082 0.1%   
Total assets Rs m10,55793,942 11.2%  
Interest coverage x71.433.1 216.1%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.80.4 193.4%   
Return on assets %13.17.6 172.5%  
Return on equity %16.014.2 112.5%  
Return on capital %23.512.6 186.5%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14612,988 8.8%   
Fx outflow Rs m3557,899 4.5%   
Net fx Rs m7915,089 15.5%   
CASH FLOW
From Operations Rs m1,4856,400 23.2%  
From Investments Rs m-620-4,985 12.4%  
From Financial Activity Rs m-753-1,775 42.4%  
Net Cashflow Rs m113-473 -23.8%  

Share Holding

Indian Promoters % 68.9 40.4 170.5%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 4.7 8.4 56.0%  
FIIs % 7.5 10.7 70.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 19.9 95.5%  
Shareholders   23,730 109,995 21.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   DISHMAN PHARMA  CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Strong Finish to the Week; Metal & Pharma Stocks Gain(Closing)

Indian share markets finished the trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 23, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS